Company Profile · Healthcare

APT Medical Inc

688617 · Shanghai
Country
China
Employees
3,401
Buffett Score
68/100
Strong
Market capCN¥35.13B
Revenue (TTM)CN¥2.9B
EBITDACN¥1.12B
Profit margin32.2%
ROE30.82%
P/E (TTM)37.61
Forward P/E0
EPSCN¥6.60
Dividend yield0.42%
52-week rangeCN¥176.28 – CN¥335.81

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.